The PKR protein kinase - An interferon-inducible regulator of cell growth and differentiation

International Journal of Hematology

Volumn 65, Issue 3, 1997, Pages 227-237

  Samuel, Charles E ^a   Kuhen, Kelli L ^a   George, Cyril X ^a   Ortega, Laura G ^a   Rende Fournier, Rosanna ^a   Tanaka, Hideo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cell growth and differentiation; Cytokine; Interferon; Protein phosphorylation; RNA dependent protein kinase PKR

Indexed keywords

CYTOKINE; INTERFERON; PKR; PROTEIN KINASE R; RNA DEPENDENT PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 17544395282     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(96)00544-0     Document Type: Article

References (89)

1. [1] Samuel CE. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 1993;268:7603-7606.
2. [2] Clemens MJ. Protein kinases that phosphorylate eIF-2 and eIF-2B, and their role in eukaryotic cell translational control. In: Translational Control. Cold Spring Harbor Press, 1996;139-172.
3. [3] Clemens MJ, Hershey JWB, Hovanessian AG et al. PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J Interferon Res 1993;13:241.
4. [4] Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987;56:727-777.
5. [5] Thomis DC, Doohan JP, Samuel CE. Mechanism of interferon action: cDNA structure, expression and regulation of the interferon-induced, RNA-dependent P1/ eIF-2a protein kinase from human cells. Virology 1992;188:33-46.
6. [6] Samuel CE. Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated protein kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci USA 1979;76:600-604.
7. [7] Jimenez-Garcia LF, Green SR, Mathews MB, Spector DL. Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNA1 in adenovirus-2-infected He-La cells. J Cell Sci 1993;106:11-22.
8. [8] Jeffrey IW, Kadereit S, Meurs EF et al. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 1995;218:17-27.
9. [9] Samuel CE. Role of the RNA-dependent protein kinase in the regulated expression of genes in transfected cells. Pharmac Ther 1992;54:307-317.
10. [10] Sonenberg N. Measures and countermeasures in the modulation of initiation factor activities by viruses. New Biol 1990;2:402-409.
11. [11] Katze MG. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol 1995;3:75-78.
12. [12] Sen GC, Lengyel P. The interferon system: a bird's eye view of its biochemistry. J Biol Chem 1992;267:5017-5020.
13. [13] Berry MJ, Knutson GS, Lasky SR, Munemutsu SM, Samuel CE. Mechanism of interferon action: purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. J Biol Chem 1985;260:11240-11247.
14. [14] Galabru J, Hovanessian AG. Autophosphorylation of the protein kinase dependent on double-stranded RNA. J Biol Chem 1987;262:15538-15544.
15. [15] George CX, Thomis DC, McCormack SJ, Svahn CM, Samuel CE. Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. Virology 1996;221:180-188.
16. [16] Thomis DC, Samuel CE. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J Virol 1993;67:7695-7700.
17. [17] Thomis DC, Samuel CE. Mechanism of interferon action. Characterization of the intermolecular autophosphorylation of PKR, the interferon-induced, RNA-dependent protein kinase. J Virol 1995;69:5195-5198.
18. [18] Romano PR, Green SR, Barber GN, Mathews MB, Hinnebusch AG. Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2α kinase DAI in Saccharomyces cerevisiae. Mol Cell Biol 1995;15:365-378.
19. [19] Kostura M, Mathews MB. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol Cell Biol 1989;9:1576-1586.
20. [20] Lasky SR, Jacobs BL, Samuel CE. Mechanism of interferon action: characterization of the sites of phosphorylation in the interferon-induced phosphoprotein P1 from mouse fibroblasts: evidence for two forms of P1. J Biol Chem 1982;257:11087-11093.
21. [21] Icely PL, Gros P, Bergeron JM, Devault A, Afar DE, Bell JC. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. J Biol Chem 1991;266:16073-16077.
22. [22] Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 1994;91:6288-6292.
23. [23] Offermann MK, Zimring J, Mellits KH et al. Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly(I).poly(C) in endothelial cells. Eur J Biochem 1995;232:28-36.
24. [24] McMillan NAJ, Chun RF, Siderovski DP et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded-RNA-dependent kinase, PKR. Virology 1995;213:413-424.
25. [25] Rice AP, Kostura M, Mathews MB. Identification of a 90-kDa polypeptide which associates with adenovirus VA RNA I and is phosphorylated by the double-stranded RNA-dependent protein kinase. J Biol Chem 1989;264:20632-20637.
26. [26] Pathak VK, Schindler D, Hershey JWB. Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol Cell Biol 1988;8:993-995.
27. [27] Thanos D, Maniatis T. NF-kB: A lesson in family values. Cell 1995;80:529-532.
28. [28] Samuel CE. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
29. [29] Schneider RJ, Shenk T. Impact of virus infection on host cell protein synthesis. Annu Rev Biochem 1987;56:317-332.
30. [30] Meurs E, Chong K, Galabru J et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990;62:379-390.
31. [31] Feng G-S, Chong K., Kumar A, Williams BRG. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc Natl Acad Sci USA 1992;89:5447-5451.
32. [32] Mellor H, Flowers KM, Kimball SR, Jefferson LS. Cloning and characterization of a cDNA encoding rat PKR, the double-stranded RNA-dependent eukaryotic initiation factor-2 kinase. Biochim Biophys Acta 1994;1219:693-696.
33. [33] Tanaka H, Samuel CE. Mechanism of interferon action. Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc Natl Acad Sci 1994;91:7995-7999.
34. [34] Baier LJ, Shors T, Shors ST, Jacobs BL. The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent interferon-induced protein kinase, PKR. Nucl Acids Res 1993;21:4830-4835.
35. [35] Katze MG, Wambach M, Wong ML, Garfinkel M, Meurs E et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated 68 000-Mr protein kinase in a cell-free system. Mol Cell Biol 1991;11:5497-5505.
36. [36] Barber GN, Tomita J, Hovanessian AG, Meurs E, Katze MG. Functional expression and characterization of the interferon-induced double-stranded RNA activated p68 protein kinase from E. coli. Biochemistry 1991;30:10356-10361.
37. [37] Thomis DC, Samuel CE. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2α protein kinase (PKR) expression in transfected mammalian cells. Proc Natl Acad Sci USA 1992;89:10837-10841.
38. [38] McCormack SJ, Thomis DC, Samuel CE. Mechanism of interferon action. Identification of an RNA-binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase. Virology 1992;188:47-56.
39. [39] Patel RC, Sen GC. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J Biol Chem 1992;267:7671-7676.
40. [40] Green SR, Mathews MB. Two RNA binding motifs in the double-stranded RNA activated protein kinase, DAI. Genes Dev 1992;6:2478-2490.
41. [41] St. Johnston D, Brown NH, Gall JG, Jantsch M. A conserved double-stranded RNA-binding domain. Proc Natl Acad Sci USA 1992;89:10979-10983.
42. [42] Kharrat A, Macias MJ, Gibson TJ, Nilges M, Pastore A. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J 1995;14:3572-3584.
43. [43] McCormack SJ, Ortega LG, Doohan JP, Samuel CE. Mechanism of interferon action. Motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA binding activity. Virology 1994;198:92-99.
44. [44] Green SR, Manche L, Mathews MB. Two functionally distinct RNA binding motifs in the regulatory domain of the protein kinase, DAI. Mol Cell Biol 1995;15:358-364.
45. [45] McMillan NA, Carpick BW, Hollis B, Toone WM, Zamanian-Daryoush M, Williams BR. Mutational analysis of the double-stranded RNA binding domain of the dsRNA-activated protein kinase, PKR. J Biol Chem 1995;270:2601-2606.
46. I and TAR RNAs. Virology 1995;206:511-519.
47. [47] Schmedt C, Green SR, Manchi L, Taylor DR, Ma Y, Mathews MB. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J Mol Biol 1995;249:29-44.
48. [48] Mathews MB, Shenk T. Adenovirus virus-associated RNA and translational control. J Virol 1991;65:5657-5662.
49. [49] Davis S, Watson JC. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc Natl Acad Sci USA 1996;93:508-513.
50. [50] Manchie L, Green SR, Schmedt C, Mathews MB. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 1992;12:5238-5248.
51. [51] Bevilacqua PC, Cech T. Minor-groove recognition of double-stranded RNA of the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 1996;35:9983-9994.
52. [52] Bischoff JR, Samuel CE. Activation of the human P1/ eIF-2 alpha protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA. Virology 1989;172:106-115.
53. [53] Hovanessian AG, Galabru J. The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur J Biochem 1987;167:467-473.
54. [54] Patel RC, Stanton P, Sen GC. Role of the amino-terminal residues of the interferon-induced protein kinase in its activation by dsRNA and heparin. J Biol Chem 1994;269:18593-18598.
55. [55] Kuhen KL, Shen X, Carlisle ER et al. Mechanism of interferon action. Structural organization of the human Pkr gene encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics 1996;36:197-201.
56. [56] Barber GN, Edelhoff S, Katze MG, Disteche CM. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17E2. Genomics 1993;16:765-767.
57. [57] Squire J, Meurs E, Chong KL, McMillan NA, Hovanessian AG, Williams BR. Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. Genomics 1993;16:768-770.
58. [58] Barber GN, Wambach M, Wong ML, Dever TE, Hinnebusch AG, Katze MG. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc Natl Acad Sci USA 1993;90:4621-4625.
59. [59] Cosentino GP, Venkatesan S, Serluca FC, Green SR, Mathews MB, Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci USA 1995;92:9445-9449.
60. [60] Patel RC, Stanton P, McMillan NM, Williams BR, Sen GC. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc Natl Acad Sci USA 1995;92:8283-8287.
61. [61] Ortega LG, McCotter MD, Henry GL, McCormack SJ, Thomis DC, Samuel CE. Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology 1996:215:31-39.
62. [62] Wu S, Kaufman RJ. Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR). J Biol Chem 1996;271:1756-1763.
63. [63] Gale M, Tan S-L, Wambach M, Katze MG. Interaction of the interferon-instructed PKR protein kinase with inhibitory proteins P58 and vaccinia virus K3L is mediated by unique domains: implication for kinase regulation. Mol Cell Biol 1996;16:4172-4181.
64. [64] Park H, Davies MV, Langland JO, Chang H-W, Nam Y-S, Tartaglia J et al. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc Natl Acad Sci USA 1994;91:4713-4717.
65. [65] Lee TG, Tang N, Thompson S, Miller J, Katze MG. The 58 000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol 1994;14:2331-2342.
66. [66] Vilcek J, Sen GC. Interferons and other cytokines. In: Fundamental Virology. Lippincott-Raven Press 1996;341-365.
67. [67] Lengyel P. Tumor-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA 1993;90:5893-5895.
68. [68] Judware R, Petryshyn R. Partial characterization of a cellular factor that regulates double-stranded RNA-dependent eIF-2α kinase in 3T3-F442A fibroblasts. Mol Cell Biol 1991;11:3259-3267.
69. [69] Judware R, Petryshyn R. Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells. J Biol Chem 1992;267:21685-21690.
70. [70] Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 1992;257:1685-1689.
71. [71] Barber GN, Tomita J, Garfinkel MS, Meurs E, Hovanessian A, Katze MG. Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed ds RNA-activated 68 000-Da protein kinase. Virology 1992;191:670-679.
72. [72] Chong KL, Feng L, Schappert K et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J 1992;11:1553-1562.
73. [73] Dever TE, Chen JJ, Barber GN et al. Mammalian eukaryotic initiation factor 2α kinase functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc Natl Acad Sci USA 1993;90:4616-4620.
74. [74] Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1993;90:232-236.
75. [75] Barber GN, Wambach M, Thompson S, Jagus R, Katze MG. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 1995;15:3138-3146.
76. [76] Donze O, Jagus R, Koromilas AE, Hershey JW, Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995;14:3828-3834.
77. [77] Barber GN, Thompson S, Lee TG et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci USA 1994;91:4278-4282.
78. [78] Tanaka N, Ishihara M, Kitagawa M et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994;77:829-839.
79. [79] Harada H, Kitagawa M, Tanaka N et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-974.
80. [80] Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, Hauser H. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 1995;11:439-445
81. [81] Barber GN, Jagus R, Meurs EF, Hovanessian AG, Katze MG. Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J Biol Chem 1995;270:17423-17428.
82. [82] Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA's 5′ cap. Nature 1990;345:544-548.
83. [83] Der SD, Lau AS. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci USA 1995;92:8841-8845.
84. [84] Henry GL, McCormack SJ, Thomis DT, Samuel CE. Mechanism of interferon action. Translational control and the RNA-dependent protein kinase (PKR): antagonists of PKR enhance the translational activity of mRNAs that include a 161 nucleotide region from reovirus S1 mRNA. J Biol Regul Homeostat Agents 1994;8:15-24.
85. [85] Yang Y-L, Reis LFL, Pavlovic J et al. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 1995;14:6095-6106.
86. [86] Resnitzky D, Yarden A, Zipori D, Kimchi A. Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 1986;46:31-40.
87. [87] Hwang SY, Hertzog PJ, Holland KA et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses. Proc Natl Acad Sci USA 1995;92:11284-11288.
88. [88] Muller U, Steinhoff U, Reis LF et al. Functional role of type I and type II interferons in antiviral defense. Science 1994;262:1918-1921.
89. [89] Benkirane M, Chun RF, Smith SM, et al. Oncogenic potential of TAR RNA-binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 1997;in press.